Dr Chioma Izzi-Engbeaya is a Clinical Academic in the Section of Endocrinology and Investigative Medicine and a Consultant Endocrinologist at Imperial College Healthcare NHS Trust. Her research and clinical interests include assessing the hormonal interactions between metabolic and reproductive systems, as well as investigating the management of obesity and obesity-related co-morbidities.
Dr Izzi-Engbeaya completed her undergraduate medical training at Guy’s Kings and St Thomas’ Medical School in 2004. During this time she also completed an Intercalated BSc in Endocrinology. Her junior doctor training posts were undertaken at various London NHS Trusts including Guy’s and St Thomas’ NHS Trust and Imperial College Healthcare NHS Trust. She became an NIHR Academic Clinical Fellow during her training as a Diabetes and Endocrinology Registrar and was subsequently awarded a 1-year Imperial Health Charity Fellowship, followed by an MRC Clinical Research Training PhD Fellowship in 2014. She completed her PhD (investigating the neuroendocrine control of metabolism and reproduction) with Professor Waljit Dhillo and Dr James Gardiner in 2018. In 2019, she was awarded an Imperial College-BRC funded IPPRF Clinical Research Fellowship, during which she investigated the impact of reproductive hormones on metabolic conditions.
Alongside her research and clinical work, Dr Izzi-Engbeaya is actively involved in medical education. In 2020, she was appointed the Academic Lead for the Implementation of the BMA Charter, and in 2021 she was appointed the Director of EDI in Imperial College School of Medicine. In addition, Dr Izzi-Engbeaya is the Pathway Director of the Pharmacology Intercalated BSc.
et al., 2023, The effects of kisspeptin on food intake in women with overweight or obesity, Diabetes, Obesity and Metabolism: a Journal of Pharmacology and Therapeutics, Vol:25, ISSN:1462-8902, Pages:2393-2397
et al., 2023, Non-alcoholic fatty liver disease in women – current knowledge and emerging concepts, Jhep Reports, ISSN:2589-5559
et al., 2023, Letter to the Editor of Clinical Endocrinology: Assessment of adrenal function in patients who survive COVID‐19, Clinical Endocrinology, Vol:98, ISSN:0300-0664, Pages:270-272
et al., 2023, Brown adipose tissue and regulation of human body weight, Diabetes - Metabolism: Research and Reviews, Vol:39, ISSN:1520-7552
et al., 2022, Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men, Frontiers in Endocrinology, Vol:13, ISSN:1664-2392